CPG 7909 Injection in Non-Small Cell Lung Cancer

NCT00070629 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small Cell Lung

Interventions

DRUG: CPG 7909
DRUG: Chemotherapy
DRUG: Chemotherapy

Sponsor

Pfizer